Christina. Eftychi, et.al., Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia., PloS one, 2012, 7

http://rdf.ncbi.nlm.nih.gov/pubmed/22348103

Christina. Eftychi, et.al., Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia., PloS one, 2012, 7

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Map3k7<tm1.1Gkl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5576979
• Map3k7<tm1.2Gkl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5576980

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased interleukin-10 secretion_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008660I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased inflammatory response_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0001846I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased circulating interleukin-1 beta level_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008641I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• decreased interleukin-10 secretion_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008661I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• prenatal lethality, complete penetrance_Map3k7<tm1.2Gkl>/Map3k7<tm1.2Gkl>
  http://metadb.riken.jp/0011091IC57BL6FVBNMap3k7tm12GklMap3k7tm12GklMap3k7tm12Gkl
• increased interleukin-1 beta secretion_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008657I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• decreased circulating interleukin-10 level_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008594I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased sensitivity to induced morbidity/mortality_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0009763I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased susceptibility to endotoxin shock_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008735I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased circulating tumor necrosis factor level_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008553I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased tumor necrosis factor secretion_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008560I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl
• increased interleukin-6 secretion_Map3k7<tm1.1Gkl>/Map3k7<tm1.1Gkl>,Lyz2<tm1(cre)Ifo>/Lyz2<+>
  http://metadb.riken.jp/0008705I129P2OlaHsdC57BL6Map3k7tm11GklMap3k7tm11GklLyz2tm1creIfoLyz2Lyz2tm1creIfoLyz2Map3k7tm11Gkl

class

http://purl.org/net/cito/citesAsAuthority

• Map3k7<tm1.1Gkl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5576979
• Map3k7<tm1.2Gkl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5576980